Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Vopr Virusol ; 60(4): 23-8, 2015.
Article in Russian | MEDLINE | ID: mdl-26665431

ABSTRACT

Comparative analysis of the clinical laboratory data from 419 children and 468 adults hospitalized during the pandemic of A (H1N1pdm 2009) and pre- and post-pandemic periods (2010-2013) showed that the clinical presentation of the pandemic influenza in patients of all ages is generally typical for influenza, and its character is determined by the degree of involvement of lungs in the process. Besides, the incidence of pneumonia in adults is statistically significantly higher than in children. During all compared periods hyperthermia (≥ 39 degrees C), hemorrhagic and dyspeptic syndrome were observed. Some differences in the main clinical manifestations of pneumonia in recovered patients and patients who died of the severe pandemic influenza were observed. The regularities of the cytokine reactions depending on the intensity of intoxication and occurrence of complications were determined in patients of all ages. Medical efficacy of inclusion of antiviral chemotherapeutic agents into complex influenza treatment was proved.


Subject(s)
Influenza A Virus, H1N1 Subtype , Influenza, Human , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Influenza A Virus, H1N1 Subtype/genetics , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza A Virus, H1N1 Subtype/metabolism , Influenza, Human/blood , Influenza, Human/epidemiology , Influenza, Human/genetics , Influenza, Human/therapy , Male , Russia/epidemiology
2.
Bull Exp Biol Med ; 148(2): 275-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-20027346

ABSTRACT

We studied interferon status in children during acute respiratory infections and found that it depends on etiology, course of the disease, and individual features of the organism. The efficiency of IFN inductor anaferon (pediatric formulation) and the possibility of its application in the therapy of children with acute respiratory infections were demonstrated.


Subject(s)
Antiviral Agents/therapeutic use , Interferon Inducers/therapeutic use , Interferons/blood , Respiratory Tract Infections/blood , Respiratory Tract Infections/drug therapy , Acute Disease , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Interferon-alpha/blood , Interferon-gamma/blood , Male , Respiratory Tract Infections/virology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...